Abstract: The present invention discloses a terminal module and a high-speed electrical connector using the same. The connector includes a number of terminal modules, a number of shielding plates, a front cover and a rear stiffener. The terminal module has grounding terminals and differential signal pairs embedded within an insulating body. Each differential signal pair have contacting portions, mounting portions and connecting portions. The insulating body defines a number of cutouts thereon with the connecting portions of the differential signal pairs partially exposed therefrom. The front cover has a U-shaped cross-section. An exposed surface of the connecting portion of the differential signal pairs is coated with an insulating thin film.

Abstract: The present invention discloses a shielding means and a high-speed, electrical connector using the same. The connector includes terminal modules, shielding means and a shell fixing the terminal modules and the shielding means. Each terminal module includes grounding terminals and differential signal pairs embedded within an insulating body. The shielding means has a number of mating tongue and a number of protruding portions formed thereon. Each mating tongue is configured to mechanically and electrically connecting to corresponding grounding terminal. The insulating body defines a number of cutouts and the grounding terminals of the terminal module are partially exposed from the cutouts. The protruding portions of the shielding means are correspondingly retained between the cutouts of the insulating body to securely connecting the shielding means on the terminal module.

Abstract: The invention discloses a data interactive display system and method, which comprises a smart wearable terminal and a display device. The smart wearable terminal includes a first NFC module, a first microprocessor, a first touch screen and a first data interaction module, wherein the first microprocessor is connected with the other three parts respectively. The display device includes a second NFC module, a second microprocessor, a second touch screen and a second data interaction module, wherein the second microprocessor is connected with the other three parts respectively. The first touch screen and the second touch screen achieve real-time synchronization between the displayed data and touch commands through a communication link established by the first data interaction module and the second data interaction module.

Abstract: The invention discloses a data interactive display system and method, which comprises a smart wearable terminal and a display device. The smart wearable terminal includes a first NFC module, a first microprocessor, a first touch screen and a first data interaction module, wherein the first microprocessor is connected with the other three parts respectively. The display device includes a second NFC module, a second microprocessor, a second touch screen and a second data interaction module, wherein the second microprocessor is connected with the other three parts respectively. The first touch screen and the second touch screen achieve real-time synchronization between the displayed data and touch commands through a communication link established by the first data interaction module and the second data interaction module.

Abstract: The present application relates generally to the treatment of peanuts, red skin peanuts and/or peanut skins with an enzyme, in particular an endopeptidase enzyme such as a subtilisin, for example, alcalase, optionally in combination with an enzyme having exopeptidase activity, or in combination with ultrasonic treatment. The peanuts, red skin peanuts and/or peanut skins being treated can be raw, wet or dry blanched, roasted, or blanched and roasted.

Abstract: Disclosed are an electronic trading method and system, and a payment platform system. The electronic trading system comprises a merchant trading system used by a merchant, a trading gateway, a bank system, a payment gateway and a payment platform system. The merchant trading system comprises a terminal used by a user and a merchant trading server. The payment platform system communicates with the merchant trading system via the trading gateway and communicates with the bank system via the payment gateway. The payment platform system is configured to receive an agreement deduction request sent from the merchant trading system, to verify the agreement deduction request, and to communicate with the bank system so as to perform a deduction according to the agreement deduction request and a predetermined payment deduction agreement after the agreement deduction request passes verification.

Abstract: The present invention relates to the use of a solution containing at least one endopeptidase to substantially reduce or completely eliminate allergenic proteins contained in the peanut (Arachis hypogea). In particular, the direct application of a solution containing at least one endopeptidase to either raw, blanched, or roasted peanuts or peanut products or derivates, has been shown to substantially reduce or completely eliminate the activity of allergenic proteins. The treated peanuts showed no degradation in quality or sensory acceptability, and have the flavor and aroma of natural whole peanuts. Hypoallergenic or non-allergenic peanuts produced in accordance with the present invention may be used as ingredients in various food products and other edible materials.

Abstract: The present invention relates to the use of a solution containing at least one endopeptidase to substantially reduce or completely eliminate allergenic proteins contained in the peanut (Arachis hypogea). In particular, the direct application of a solution containing at least one endopeptidase to either raw, blanched, or roasted peanuts or peanut products such as peanut butter or derivates, has been shown to substantially reduce or completely eliminate the activity of allergenic proteins. The treated peanuts and peanut products showed no degradation in quality or sensory acceptability, and have the flavor and aroma of natural whole peanuts and untreated peanut products. Hypoallergenic or non-allergenic peanuts or peanut products produced in accordance with the present invention may be used as ingredients in various food products and other edible materials.

Abstract: The present invention relates to the use of a solution containing at least one endopeptidase to substantially reduce or completely eliminate allergenic proteins contained in the peanut (Arachis hypogea). In particular, the direct application of a solution containing at least one endopeptidase to either raw, blanched, or roasted peanuts or peanut products or derivates, has been shown to substantially reduce or completely eliminate the activity of allergenic proteins. The treated peanuts showed no degradation in quality or sensory acceptability, and have the flavor and aroma of natural whole peanuts. Hypoallergenic or non-allergenic peanuts produced in accordance with the present invention may be used as ingredients in various food products and other edible materials.

Abstract: The invention provides devices for the disruption of one or more layers of skin and methods of their use to administer therapeutic agents, e.g., antigens or drugs. The devices are designed to disrupt a defined area of skin. The defined area can approximate the area that a patch or other suitable vehicle for therapeutic agent, e.g., drug or vaccine, delivery is designed to contact. Exemplary devices employ a mask to define the area to be disrupted. Other devices disrupt a defined area by rotating in place. For devices that employ a mask that is secured to the skin, the invention provides methods of disrupting the stratum corneum by first securing the mask to the skin and then disrupting the skin. For rotating devices, the disrupting member is simply placed against the skin and actuated to effect disruption.

Abstract: A protein-in-adhesive patch for transcutaneous immunization is described with at least four different components: (i) backing layer; (ii) pressure-sensitive adhesive adhering to the backing layer; (iii) at last one immunologically-active protein of an immunogenic formulation applied to the pressure-sensitive adhesive layer opposite the backing layer and/or incorporated in the pressure-sensitive adhesive layer such that the at least one protein is in contact with adhesive; and (iv) stabilizer which maintains the immunological activity of the at least one protein under ambient conditions.